Effects of arginine vasopressin on human anxiety and associations with sex, dose, and V1a-receptor genotype

ConclusionsExogenous AVP has modest sex- and dose-dependent effects on anxiety/affect in humans. Further, allelic variation in the V1a promoter appears associated with responsiveness to AVP ’s effects and, at least in women, to stable levels of anxiety/affect.

Source: Psychopharmacology - February 15, 2024 Category: Psychiatry Source Type: research